CN Patent

CN110845504A — 合成赞布替尼的新方法

Assigned to Wuhan Jiuzhou Yumin Medical Technology Co ltd · Expires 2020-02-28 · 6y expired

What this patent protects

本发明涉及一种合成赞布替尼的新方法。本发明的合成路线反应步骤少，收率高，具有操作性良好，工艺简单等特点，而且不涉及低温反应，可有效实现产业化放大生产。

USPTO Abstract

本发明涉及一种合成赞布替尼的新方法。本发明的合成路线反应步骤少，收率高，具有操作性良好，工艺简单等特点，而且不涉及低温反应，可有效实现产业化放大生产。

Drugs covered by this patent

Patent Metadata

Patent number
CN110845504A
Jurisdiction
CN
Classification
—
Expires
2020-02-28
Drug substance claim
No
Drug product claim
No
Assignee
Wuhan Jiuzhou Yumin Medical Technology Co ltd
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.